Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of new designer proteins engineered using advanced Artificial Intelligence (AI) based design ...
Bio-Techne receives favorable ruling on second Miltenyi Biotec claim
Bio-Techne (TECH) prevailed on another claim that Miltenyi Biotec KG commercialized antibodies developed based on information obtained by ...
Bio-Techne Wins Second Claim Of Reverse Engineering By Miltenyi Biotec
Bio-Techne Corp. (TECH), a life sciences company, announced Tuesday that it has won a second claim of reverse engineering by Miltenyi ...
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors despite daily gains
This was the stock's fourth consecutive day of gains.
Morningstar1d
Bio-Techne Corp TECH
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Key Trends and Growth Opportunities in the Laboratory Animal Models, 3D Cultures, and Organoids Market
The report includes company profiles of major players within the industry, including Thermo Fisher Scientific, Corning, ...
Cell Therapy Technologies Market to Hit US$ 6.80 Billion by 2029 with 11.0% CAGR | MarketsandMarkets
The global Cell Therapy Technologies market, valued at US$3.89 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, reaching US$4.03 ...
Cell Therapy Technologies Market to Hit US$ 6.80 Billion by 2029 with 11.0% CAGR | MarketsandMarkets™
The global Cell Therapy Technologies market, valued at US$3.89 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, ...